Medidata Advances AI-Powered Clinical Innovation to Transform Patient Care and Drug Development

-Medidata, a Dassault Systèmes brand, reaffirms its vision and commitment to advancing the life sciences industry and transforming patient experie...

February 04, 2025 | Tuesday | News
Revive Therapeutics Focuses on Bucillamine for Medical Countermeasures and Nerve Agent Exposure Treatment

 Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences com...

February 04, 2025 | Tuesday | News
Halozyme's Subcutaneous RYBREVANT® Formulation Receives Positive CHMP Opinion for Advanced NSCLC Treatment

 Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) announced that Janssen-Cilag International NV, a Johnson & Johnson company, received a...

February 04, 2025 | Tuesday | News
Merck's CAPVAXIVE™ Pneumococcal Vaccine Receives Positive CHMP Recommendation for Approval in the European Union

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced  that the Committee for Medicinal Products for Human Use (CHMP) of ...

February 03, 2025 | Monday | News
Zerion Pharma Partners with Aché to Enhance Global Oncology and Neuroscience Drugs Using Dispersome® Technology

Zerion Pharma A/S  announces a partnership with Aché Laboratorios Farmacêuticos S.A. (“ACHÉ”), a major Brazilian p...

January 30, 2025 | Thursday | News
GHIT Fund Announces JPY 2 Billion Investment in New Diagnostics and Drugs for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight...

January 30, 2025 | Thursday | News
Datar Cancer Genetics Launches AI-Powered Video Reporting Service for Chemosensitivity Testing

Datar Cancer Genetics (DCG) has launched a revolutionary video reporting service for in vitro chemosensitivity testing, powered by AI-based technology. Thi...

January 29, 2025 | Wednesday | News
Pfizer to Present Groundbreaking Genitourinary Cancer Research at ASCO GU 2025

Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society of Clinical Oncology Genitour...

January 29, 2025 | Wednesday | News
Neurocrine Biosciences Secures Global Rights to Osavampator, a Potential Breakthrough Treatment for Major Depressive Disorder

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced it has amended its agreement with Takeda to develop and commercialize osavampator (NB...

January 28, 2025 | Tuesday | News
Merck’s WELIREG® (belzutifan) Accepted for Priority Review by FDA for Advanced Pheochromocytoma and Paraganglioma

 Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has accepted for prior...

January 28, 2025 | Tuesday | News
Bristol Myers Squibb Reports Significant Progression-Free Survival Benefit for Opdivo® Plus Yervoy® in MSI-H/dMMR Metastatic Colorectal Cancer

Bristol Myers Squibb (NYSE: BMY) announced results of an analysis from the three-arm Phase 3 CheckMate -8HW trial evaluating Opdivo® (ni...

January 27, 2025 | Monday | News
Pfizer's BRAFTOVI® Combination Therapy Demonstrates Significant Clinical Benefit in Metastatic Colorectal Cancer with BRAF V600E Mutation

 Pfizer Inc. (NYSE: PFE) announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination ...

January 27, 2025 | Monday | News
AbbVie and Neomorph Forge Partnership to Develop Novel Molecular Glue Degraders for Oncology and Immunology

AbbVie (NYSE: ABBV) and Neomorph, Inc. announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple tar...

January 24, 2025 | Friday | News
Akeso’s Cadonilimab Combination Therapy Shows Landmark Survival Benefits in Advanced Gastric Cancer, Published in Nature Medicine

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine published the results of ...

January 23, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close